Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven R Meshnick

Showing results (131-140 of 239) with videos related to

Pageof 24
Sort By:
The Journal of Infectious Diseases|June 18, 2005
Efficacy of DB289 in Thai patients with Plasmodium vivax or acute, uncomplicated Plasmodium falciparum infectionsPatrick Yeramian, Steven R Meshnick, Srivicha Krudsood, et al.
Malaria Journal|August 10, 2018
Correction to: Individual and household characteristics of persons with Plasmodium falciparum malaria in sites with varying endemicities in Kinshasa Province, Democratic Republic of the CongoMelchior Kashamuka Mwandagalirwa, Lauren Levitz, Kyaw L Thwai, et al.
Scientific Reports|June 18, 2013
Comparative population structure of Plasmodium falciparum circumsporozoite protein NANP repeat lengths in Lilongwe, MalawiNatalie M Bowman, Seth Congdon, Tisungane Mvalo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 24, 2012
Antenatal receipt of sulfadoxine-pyrimethamine does not exacerbate pregnancy-associated malaria despite the expansion of drug-resistant Plasmodium falciparum: clinical outcomes from the QuEERPAM studySteve M Taylor, Alejandro L Antonia, Ebbie Chaluluka, et al.
Journal of Clinical Microbiology|December 30, 2011
Individual Plasmodium vivax msp1 variants within polyclonal P. vivax infections display different propensities for relapseJessica T Lin, Jonathan J Juliano, Oksana Kharabora, et al.
The Journal of Infectious Diseases|June 1, 2007
CD16+ monocyte subset preferentially harbors HIV-1 and is expanded in pregnant Malawian women with Plasmodium falciparum malaria and HIV-1 infectionAnthony Jaworowski, Deborah D Kamwendo, Philip Ellery, et al.
Lancet (London, England)|June 9, 2004
Impairment of humoral immunity to Plasmodium falciparum malaria in pregnancy by HIV infectionAdele M Mount, Victor Mwapasa, Salenna R Elliott, et al.
Plos One|December 7, 2018
Bacterial microbiome of the chigger mite Leptotrombidium imphalum varies by life stage and infection with the scrub typhus pathogen Orientia tsutsugamushiLoganathan Ponnusamy, Alexandra C Willcox, R Michael Roe, et al.
Emerging Infectious Diseases|October 2, 2008
Molecular surveillance for multidrug-resistant Plasmodium falciparum, CambodiaNaman K Shah, Alisa P Alker, Rithy Sem, et al.
Antimicrobial Agents and Chemotherapy|April 17, 2013
Nonrandomized controlled trial of artesunate plus sulfadoxine-pyrimethamine with or without primaquine for preventing posttreatment circulation of Plasmodium falciparum gametocytesNaman K Shah, Allan Schapira, Jonathan J Juliano, et al.
Pageof 24

Showing results (131-140 of 239) with videos related to

Sort By:
Pageof 24
The Journal of Infectious Diseases|June 18, 2005
Efficacy of DB289 in Thai patients with Plasmodium vivax or acute, uncomplicated Plasmodium falciparum infectionsPatrick Yeramian, Steven R Meshnick, Srivicha Krudsood, et al.
Malaria Journal|August 10, 2018
Correction to: Individual and household characteristics of persons with Plasmodium falciparum malaria in sites with varying endemicities in Kinshasa Province, Democratic Republic of the CongoMelchior Kashamuka Mwandagalirwa, Lauren Levitz, Kyaw L Thwai, et al.
Scientific Reports|June 18, 2013
Comparative population structure of Plasmodium falciparum circumsporozoite protein NANP repeat lengths in Lilongwe, MalawiNatalie M Bowman, Seth Congdon, Tisungane Mvalo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 24, 2012
Antenatal receipt of sulfadoxine-pyrimethamine does not exacerbate pregnancy-associated malaria despite the expansion of drug-resistant Plasmodium falciparum: clinical outcomes from the QuEERPAM studySteve M Taylor, Alejandro L Antonia, Ebbie Chaluluka, et al.
Journal of Clinical Microbiology|December 30, 2011
Individual Plasmodium vivax msp1 variants within polyclonal P. vivax infections display different propensities for relapseJessica T Lin, Jonathan J Juliano, Oksana Kharabora, et al.
The Journal of Infectious Diseases|June 1, 2007
CD16+ monocyte subset preferentially harbors HIV-1 and is expanded in pregnant Malawian women with Plasmodium falciparum malaria and HIV-1 infectionAnthony Jaworowski, Deborah D Kamwendo, Philip Ellery, et al.
Lancet (London, England)|June 9, 2004
Impairment of humoral immunity to Plasmodium falciparum malaria in pregnancy by HIV infectionAdele M Mount, Victor Mwapasa, Salenna R Elliott, et al.
Plos One|December 7, 2018
Bacterial microbiome of the chigger mite Leptotrombidium imphalum varies by life stage and infection with the scrub typhus pathogen Orientia tsutsugamushiLoganathan Ponnusamy, Alexandra C Willcox, R Michael Roe, et al.
Emerging Infectious Diseases|October 2, 2008
Molecular surveillance for multidrug-resistant Plasmodium falciparum, CambodiaNaman K Shah, Alisa P Alker, Rithy Sem, et al.
Antimicrobial Agents and Chemotherapy|April 17, 2013
Nonrandomized controlled trial of artesunate plus sulfadoxine-pyrimethamine with or without primaquine for preventing posttreatment circulation of Plasmodium falciparum gametocytesNaman K Shah, Allan Schapira, Jonathan J Juliano, et al.
Pageof 24